NCT07120347 Remote Sensing for ADRD-Specific Activities Identification in Older Adults
| NCT ID | NCT07120347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Missouri-Columbia |
| Condition | Alzheimer Disease and Related Dementias (ADRD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2024-08-01 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern. In the United States, more than 6.7 million individuals aged 65 and older are living with ADRD, and projected annual healthcare costs are expected to reach $1 trillion by 2050. This underscores the need for deeper understanding and innovative support. To address the unique challenges associated with ADRD, such as cognitive decline, personalized strategies that promote independent well-being are essential. Smart-home sensors can support older adults with ADRD as they continue to live in their homes. These sensors provide real-time data on health and daily activities, offering insights into their daily lives. However, adoption of these technologies is low, and the practical application of AI remains limited. This highlights the need for further research to make these devices more accessible to this population. The investigators' aims include: Conducting focus groups with individuals with and without ADRD and their caregivers to identify daily activities that can be measured using in-home sensors; Collecting in-home sensor data from older adults with and without ADRD; and Using AI to develop a tool for recognizing daily activities. The integration of smart-home sensors with advanced data-analysis techniques holds significant potential for transforming the support and care provided to individuals with ADRD. Ultimately, the investigators' findings will contribute to improving the quality of life for affected individuals and alleviating the burden on caregivers and healthcare systems.
Eligibility Criteria
Inclusion Criteria * Community-dwelling, English-speaking adults aged ≥ 50 years * Clinical diagnosis of mild cognitive impairment or mild dementia (ADRD) * Diagnosis established by a neuropsychologist, neurologist, or geriatrician within the University of Missouri Healthcare System * Diagnosis confirmed using the latest consensus criteria and verified through record review * No restriction on the etiology of the cognitive disorder (e.g., Alzheimer's disease, vascular dementia, mixed dementia) Exclusion Criteria * Clinical Dementia Rating (CDR) global score \> 1 (moderate or severe dementia) * Cognitive or functional impairments that would preclude meaningful participation in daily activities
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07120347 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Alzheimer Disease and Related Dementias (ADRD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07120347 currently recruiting?
Yes, NCT07120347 is actively recruiting participants. Contact the research team at knoolee@missouri.edu for enrollment information.
Where is the NCT07120347 trial being conducted?
This trial is being conducted at Columbia, United States.
Who is sponsoring the NCT07120347 clinical trial?
NCT07120347 is sponsored by University of Missouri-Columbia. The trial plans to enroll 16 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.